Effect of infliximab therapy on anti-cyclic citrullinated peptide antibodies levels in patients with rheumatoid arthritis

被引：0
|
作者：
Kyriazis, NC
Papalopoulou, M
Balla, M
机构：
[1] Gen Hosp Karditsa, Dept Rheumatol, Kardhitsa, Greece
[2] Gen Hosp Karditsa, Dept Microbiol, Kardhitsa, Greece
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：172 / +
页数：2
相关论文
共 50 条
  • [1] Effect on rheumatoid factor and anti-Cyclic Citrullinated Peptide Antibodies Levels of treatment with Infliximab and Adalimumab in patients with Rheumatoid Arthritis
    Baos, Selene
    Plasencia, Chamaida
    Ramiro, Susana
    Moral, Rosario
    Diez, Jesus
    Martin-Mola, E.
    Balsa, Alejandro
    Pascual-Salcedo, Dora
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S489 - S489
  • [2] Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
    De Rycke, L
    Verhelst, X
    Kruithof, E
    Van den Bosch, F
    Hoffman, IEA
    Veys, EM
    De Keyser, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 299 - 302
  • [3] Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and comorbidity
    Stamenkovic, Doris
    Stiglic-Rogoznica, Nives
    Stiglic, Mirna
    Avancini-Dobrovic, Viviana
    Grubisic-Karavanic, Vlasta
    Frlan-Vrgoe, Ljubinka
    Radovic, Endi
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 706 - 707
  • [4] The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
    Chen, HA
    Lin, KC
    Chen, CH
    Liao, HT
    Wang, HP
    Chang, HN
    Tsai, CY
    Chou, CT
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (01) : 35 - 39
  • [5] Anti-cyclic citrullinated peptide antibody levels decrease following infliximab and etanercept therapy in rheumatoid arthritis
    Chan, MT
    Owen, P
    Shenker, N
    Michell, E
    Carmichael, C
    Dunphy, J
    McHugh, NJ
    RHEUMATOLOGY, 2005, 44 : I71 - I71
  • [6] Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis
    Pinheiro, GC
    Scheinberg, MA
    da Silva, MA
    Maciel, S
    ANNALS OF INTERNAL MEDICINE, 2003, 139 (03) : 234 - 235
  • [7] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers, V. Michael
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 400 - 401
  • [8] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    V Michael Holers
    Nature Clinical Practice Rheumatology, 2006, 2 : 400 - 401
  • [9] Anti-cyclic citrullinated peptide antibodies in juvenile rheumatoid arthritis patients.
    Moore, TL
    Chung, AK
    Kietz, DA
    Pepmueller, PH
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S338 - S338
  • [10] Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis
    Spadaro, A
    Riccieri, V
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) : 1241 - 1242
12345